Department of Cardiovascular Medicine, Shinshu University School of Medicine, Nagano, Japan.
Department of Cardiovascular Medicine, Shinshu University School of Medicine, Nagano, Japan.
J Cardiol. 2022 Oct;80(4):339-343. doi: 10.1016/j.jjcc.2022.05.006. Epub 2022 Jun 11.
Transvenous lead extraction (TLE) is an established procedure for the management of cardiovascular implantable electronic devices. However, some difficulties and risks of complications still exist, especially in old and adhered leads. Evolution RL (Cook Medical, Bloomington, IN, USA) is a newly introduced device for TLE; however, no clinical results have been reported in Japan, and the results with older leads are unknown. We investigated the efficacy and safety of Evolution RL and its usefulness for old leads at two TLE centers in Japan.
A total of 27 consecutive patients who underwent lead extraction using Evolution RL at Shinshu University Hospital and Tokyo Women's Medical University Hospital from September 2017 to December 2019 were retrospectively enrolled. We examined the backgrounds of the patients and leads and investigated the efficacy and safety of the procedures. We divided the leads into two groups according to the number of years of implantation (10 years) and compared the results.
Among the 27 patients, 20 (74.1%) were men, and the median age was 62 (14-91) years. The total number of leads was 58, and the median implantation duration was 136 months (8-448). We achieved clinical success in all patients and complete procedural success in 24 patients (88.9%). In three patients, the broken tip of the lead remained in the heart. No major complications were noted. Of the 58 leads, there were 34 leads with more than 10 years of implantation, with significantly more Evolution RLs used (94.1% vs. 54.2%, p = 0.001) and significantly higher percentages of Evolution 11Fr, 13Fr, and steady sheaths used (79.4% vs. 33.3%, p = 0.001, 52.9% vs. 16.7%, p = 0.006, and 64.7% vs. 20.8%, p = 0.001, respectively).
In two TLE centers in Japan, Evolution RL was shown to be safe and effective, even in leads older than 10 years.
经静脉导线拔除术(TLE)是一种用于处理心血管植入式电子设备的成熟手术。然而,在某些情况下,仍然存在一些困难和并发症风险,尤其是对于老旧且粘连的导线。Evolution RL(库克医疗,美国印第安纳州布鲁明顿)是一种新推出的 TLE 设备,但在日本尚未报道其临床结果,对于老旧导线的效果也不明确。我们在日本的两家 TLE 中心调查了 Evolution RL 的疗效和安全性及其对老旧导线的应用价值。
回顾性纳入 2017 年 9 月至 2019 年 12 月期间在信州大学医院和东京女子医科大学医院使用 Evolution RL 进行导线拔除的 27 例连续患者。我们检查了患者和导线的背景,并调查了手术的疗效和安全性。我们根据植入年限(10 年)将导线分为两组,并比较了结果。
27 例患者中,20 例(74.1%)为男性,中位年龄为 62(14-91)岁。总导线数为 58 根,中位植入时间为 136 个月(8-448)。所有患者均获得临床成功,24 例(88.9%)达到完全手术成功。在 3 例患者中,导线的断裂尖端仍残留在心脏内。未发生重大并发症。58 根导线中,有 34 根植入时间超过 10 年,Evolution RL 的使用明显更多(94.1% vs. 54.2%,p=0.001),Evolution 11Fr、13Fr 和稳定鞘的使用率也明显更高(79.4% vs. 33.3%,p=0.001;52.9% vs. 16.7%,p=0.006;64.7% vs. 20.8%,p=0.001)。
在日本的两家 TLE 中心,Evolution RL 被证明是安全有效的,即使是在 10 年以上的老旧导线上。